CompoAtlas

GINKGO BILOBA

Food supplement declared in France, declaration No 2017-11-1136, decision dated 29 November 2017

GINKGO BILOBA (123 GELULES) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
123 GELULES
Food business operator placing the product on the market
SAS NATURE ET PLANTES
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Comprimé
Daily dose
3
Directions for use
A utiliser dans le cadre d'une alimentation équilibrée
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Sous anticoagulants, Sous antidépresseurs

Declaration 284773, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Ginkgo biloba L.FeuillePoudre (de plantes séchées ou broyées)1,200 mg

Additives

E504, E553b

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Ne pas dépasser la dose journalière recommandée;

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

Brand : 123 GELULES

List recorded in 2017. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line